Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis.
暂无分享,去创建一个
Yan Liu | Damien C Weber | Enrico Clementel | Loïc Feuvret | M. J. van den Bent | Yan Liu | C. Hurkmans | B. Baumert | S. Collette | E. Clementel | D. Weber | L. Feuvret | Brigitta G Baumert | Coen W Hurkmans | Raquel Bar-Deroma | Martin van den Bent | Sandra Collette | Karen Van Beek | André N Abrunhosa-Branquinho | A. Abrunhosa-Branquinho | K. van Beek | R. Bar-Deroma
[1] Christopher G Willett,et al. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. , 2012, International journal of radiation oncology, biology, physics.
[2] Damien C Weber,et al. Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] W. Straube,et al. Quality assurance of radiotherapy in the ongoing EORTC 22042–26042 trial for atypical and malignant meningioma: results from the dummy runs and prospective individual case Reviews , 2013, Radiation Oncology.
[4] R. Hatlevoll,et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: A prospective multicenter trial of the scandinavian glioblastoma study group , 1981, Cancer.
[5] Damien C Weber,et al. QA makes a clinical trial stronger: evidence-based medicine in radiation therapy. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] N. Laperriere,et al. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] Quynh-Thu Le,et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] J. Galvin,et al. Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. , 2014, International journal of radiation oncology, biology, physics.
[9] J. Bekelman,et al. Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: a systematic review. , 2009, International journal of radiation oncology, biology, physics.
[10] E. Alexander,et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.
[11] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[12] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[13] Claus Belka,et al. ESTRO-ACROP guideline "target delineation of glioblastomas". , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Damien C Weber,et al. Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Brian O'Sullivan,et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Damien C Weber,et al. EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Winand N M Dinjens,et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Daniel Berger,et al. Four years with FALCON - an ESTRO educational project: achievements and perspectives. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] Satoshi Ishikura,et al. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care. , 2008, Japanese journal of clinical oncology.
[20] Damien C Weber,et al. Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: First evaluation of quality of radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] E. Shaw,et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D. Brachman,et al. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study , 2017, The Lancet.